ADHD Drug Makers Must Warn Of Side Effects: FDA

Law360, New York (February 21, 2007, 12:00 AM EST) -- The U.S. Food and Drug Administration on Wednesday ordered manufacturers of drugs prescribed to treat attention deficit hyperactivity disorder to develop guides to alert patients of possible risks, including mental problems, heart problems and sudden death.

The agency said it has directed the manufacturers of all drug products approved for the treatment of ADHD to develop patient medication guides to alert patients to possible cardiovascular risks and risks of adverse psychiatric symptoms associated with the medicines, and to advise them of precautions that can be taken....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.